Search Results

Filter
  • 1-10 of  1,805 results for ""LYMPHOPROLIFERATIVE disorders""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation: a case report, meta-analysis, and systematic review.

  • Authors : Su YY; Department of Hematology, Qilu Hospital of Shandong University, 107 West Wenhua Road, Jinan, Shandong, 250012, China.; Yu YF

Subjects: Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/complications ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects ; Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/etiology

  • Source: Diagnostic pathology [Diagn Pathol] 2024 Sep 07; Vol. 19 (1), pp. 122. Date of Electronic Publication: 2024 Sep 07.Publisher: BioMed Central Country of Publication: England NLM ID: 101251558 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Clinical epidemiology of Epstein-Barr virus-associated Lymphoproliferative Disorders (EBV-LPDs) in hospitalized children: A six-year multi-institutional study in China.

  • Authors : Dilmurat D; Beijing Key Laboratory of Pediatric Respiratory Infectious Diseases, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, Laboratory of Infection and Virology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, China.; Research Unit of Critical Infection in Children, 2019RU016, Chinese Academy of Medical Sciences, Beijing, 100045, China.

Subjects: Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/epidemiology ; Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/virology ; Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/epidemiology

  • Source: Italian journal of pediatrics [Ital J Pediatr] 2024 Jul 02; Vol. 50 (1), pp. 125. Date of Electronic Publication: 2024 Jul 02.Publisher: BioMed Central Country of Publication: England NLM ID: 101510759 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

A case of adult-onset X-linked lymphoproliferative disease mimicking pulmonary infection.

  • Authors : Xu J; National Center for Respiratory Medicine, China-Japan Friendship Hospital, Beijing, 100029, China.; State Key Laboratory of Respiratory Health and Multimorbidity, China-Japan Friendship Hospital, Beijing, 100029, China.

Subjects: Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/diagnosis ; Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/drug therapy; Humans

  • Source: BMC infectious diseases [BMC Infect Dis] 2024 Dec 18; Vol. 24 (1), pp. 1399. Date of Electronic Publication: 2024 Dec 18.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Hepatic and lung methotrexate-associated polymorphic lymphoproliferative disorders arising during postoperative follow-up of renal cell carcinoma: a case report.

  • Authors : Miyamoto Y; Department of Urology, Faculty of Medicine, Miyazaki University Hospital, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.; Kawasoe C

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/drug therapy ; Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/complications

  • Source: Journal of medical case reports [J Med Case Rep] 2023 Dec 22; Vol. 17 (1), pp. 524. Date of Electronic Publication: 2023 Dec 22.Publisher: BioMed Central Country of Publication: England NLM ID: 101293382 Publication Model: Electronic Cited Medium:

Record details

×
Report

Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA.

  • Authors : Veltmaat N; Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.; Zhong Y

Subjects: Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/genetics ; Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/genetics ; Cell-Free Nucleic Acids*/Cell-Free Nucleic Acids*/Cell-Free Nucleic Acids*/genetics

  • Source: Journal of hematology & oncology [J Hematol Oncol] 2023 Sep 14; Vol. 16 (1), pp. 104. Date of Electronic Publication: 2023 Sep 14.Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV + PTLD).

Subjects: Lymphoproliferative Disorders* ; Epstein-Barr Virus Infections*; Humans

  • Source: Orphanet journal of rare diseases [Orphanet J Rare Dis] 2024 Aug 23; Vol. 19 (1), pp. 308. Date of Electronic Publication: 2024 Aug 23.Publisher: BioMed Central Country of Publication: England NLM ID: 101266602 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Clinicopathological findings, prognosis, and Epstein-Barr virus infection in rheumatoid arthritis patients with other iatrogenic immunodeficiency-associated T- and NK-cell lymphoproliferative disorders.

  • Authors : Kimura S; Graduate School of Medical Sciences, Division of Pathomorphology, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka, 8140180, Japan.; Department of Pathology, Faculty of Medicine, and Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka, 8140180, Japan.

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/complications ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/pathology

  • Source: BMC cancer [BMC Cancer] 2022 Dec 22; Vol. 22 (1), pp. 1342. Date of Electronic Publication: 2022 Dec 22.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the literature.

  • Authors : Ogawa A; Department of Breast Surgery, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan. .; Nakagawa T

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/complications ; Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/diagnosis

  • Source: Journal of medical case reports [J Med Case Rep] 2022 Feb 07; Vol. 16 (1), pp. 49. Date of Electronic Publication: 2022 Feb 07.Publisher: BioMed Central Country of Publication: England NLM ID: 101293382 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Serotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein-Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV + lymphoproliferative disorders.

  • Authors : Ahmadi E; Department of Virology, Faculty of Medical Sciences, Tarbiat Modares University, P.O. Box 14155-331, Tehran, Iran.; Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, 364 Plantation Street, Worcester, MA, 01605, USA.

Subjects: Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/complications ; Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/therapy ; Lymphoproliferative Disorders*

  • Source: Virology journal [Virol J] 2021 Nov 18; Vol. 18 (1), pp. 223. Date of Electronic Publication: 2021 Nov 18.Publisher: BioMed Central Country of Publication: England NLM ID: 101231645 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

A unique case of a fulminant clonal CD8-positive T-cell lymphoproliferative disorder with CNS involvement.

  • Authors : Mesbah-Oskui L; Division of Neurology, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. .; Alabkal J

Subjects: Epstein-Barr Virus Infections* ; Central Nervous System Neoplasms* ; Lymphoproliferative Disorders*

  • Source: BMC neurology [BMC Neurol] 2023 Sep 15; Vol. 23 (1), pp. 329. Date of Electronic Publication: 2023 Sep 15.Publisher: BioMed Central Country of Publication: England NLM ID: 100968555 Publication Model: Electronic Cited Medium:

Record details

×
  • 1-10 of  1,805 results for ""LYMPHOPROLIFERATIVE disorders""